Colorectal Neoplasia and the Microbiome: Dysplasia, Probiotics, and Fusobacteria provides foundational knowledge on the gut microbiome and evidence for an association with colorectal neoplasia. It covers the role of microbiota in causing adenomatous polyps and colorectal cancer as well as the modulatory effect of diet and probiotics. Chapters explain a foundational history of microbiology in the colon, the epidemiology of colon polyps and cancer, dysbiosis, the role of immunology and bacteria, and the diet. The book combines medical and scientific aspects to show mechanistic aspects between microbiota and hosts, clearly presenting the association between microbiota, colonic lesions and possible causal links.
The book is essential reading for everyone working with human microbiota including basic scientists, physiologists of the intestine, experts in intestinal microbiota, gastroenterologists, oncologists and surgeon.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
1. History of microbiology in colon2. epidemiology of colon polyps and cancer
3. Streptococcus galactolytica
4. Bacterodies
5. Dysbiosis and probiotics
6. Fusobacteria microbiology
7. Dysbiosis dynamics
8. Immmunology and bacteria in colon cancer
9. Diet and bacteria
Authors
Martin H. Floch Clinical Professor of Medicine, Section of Gastroenterology and Nutrition, Yale University School of Medicine, Norwalk Hospital, Norwalk, CT, USA.Dr. Floch is a Clinical Professor of Medicine at Yale University where he recently formed the Fellow's Clinic in the Digestive Disease Section supervising all gastrointestinal trainees in consultation on problem cases. He is a Master of the American College of Gastroenterology (MACG) and an American Gastroenterology Association Fellow (AGAF) as well as a Fellow of the American College of Physicians (FACP). He formerly was Chairman of Medicine at Norwalk Hospital and the Founding Chief of Gastroenterology and Nutrition in Norwalk. He is Editor-in-Chief of Journal of Clinical Gastroenterology and has written five books including the 2nd edition of the textbook "Netter's Gastroenterology?.
Dr. Floch is renowned for his work in gastric and intestinal diseases and probiotics. He lectures nationally and internationally, haven given Grand Rounds at Harvard, Brown, UMass, and UConn among others. He is a consultant to Pfizer, Proctor & Gamble, Dannon, Shire and Biocodex.
His research has been extensive in gastroenterology having had grants from the Armed Forces and National Institute of Health.
Dr. Floch has a FWCI of 1.18 and has the majority (76%) of his content published in gastroenterology journals. 8.7% of his work appears in the top 10% most cited journals worldwide.
Dr. Floch has experience with national, international, institutional and single authorship.
![Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030] - Product Image](http://www.researchandmarkets.com/product_images/12371/12371581_60px_jpg/human_microbiome_market_[20242030].jpg)
